Abivax SA (2X1) Drug Pipeline
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Abivax SA (DE:2X1) have in its pipeline
Abivax SA DE:2X1 is currently developing the following drugs: Obefazimod, Abx464, Abx464, Caffeine, Fluvoxamine, Abx196, Methotrexate, Abx464 50Mg, Abx464 100Mg, Abx464 25Mg, Abx464 50Mg, Abx464 100Mg, Abx464 50Mg, Abx464 150Mg, Abx464 Single Dose, Abx464 Repeated Dose, Abx203 Therapeutic Hepatitis B Vaccine Treatment Arm. These drug candidates are in various stages of clinical development as the company works toward FDA approval.